Aurobindo received Zidovudine approval from MCC South Africa

Aurobindo Pharma Ltd has announced that the Company has received one more marketing authorization approval from Medicines Control Council (MCC) of South Africa. The Council has approved Zidovudine Oral Solution 50mg/5ml. This is the eleventh approval and sixth in ARV class from this country.

Zidovudine is in the class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs), which help keep the AIDS virus from reproducing. it is intended for use with other ARV agents for the treatment of HIV.

The stock was trading at Rs.742.25, down by Rs.2.50 or 0.34%. The stock hit an intraday high of Rs.750 and low of Rs.742.15. The total traded quantity was 28082 at an average price of Rs.745.79 resulting in a turnover of Rs.209.43 Lakhs.

Source : Equity Bulls

Keywords